308
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Adverse outcomes in obstetric-atypical haemolytic uraemic syndrome: a case series analysis

, &
Pages 2853-2859 | Received 04 Jan 2018, Accepted 06 Mar 2018, Published online: 01 Apr 2018

References

  • Fakhouri F, Vercel C, Frémeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol. 2012;7(12):2100–2106.
  • Machado S, Figueiredo N, Borges A, et al. Acute kidney injury in pregnancy: a clinical challenge. J Nephrol. 2012;25(1):19–30.
  • Loirat C, Fakhouri F, Ariceta G, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(1):15–39.
  • Goodship TH, Cook HT, Fakhouri F, et al. Atypical haemolytic uremic syndrome and C3 glomerulopathy: conclusions from a ‘Kidney Disease: improving Global Outcomes’ (KDIGO) Controversies Conference. Kidney Int. 2017;91(3):539–551.
  • Laurence J, Haller H, Mannucci PM, et al. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Clin Adv Hematol Oncol. 2016;14(Suppl 11):2–15.
  • Fakhouri F, Frémeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? Nat Clin Pract Nephrol. 2007;3(12):679–687.
  • Campistol JM, Arias M, Ariceta G, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2015;35(5):421–447.
  • Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uremic syndrome. Semin Nephrol. 2013;33(6):508–530.
  • Noris M, Remuzzi G. Atypical haemolytic-uremic syndrome. N Engl J Med. 2009;361(17):1676–1687.
  • George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654–666.
  • Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554–562.
  • Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844–1859.
  • Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol. 2017;30(3):347–362.
  • European Medicines Agency. Soliris (eculizumab) [summary of product characteristics]. Paris, France: Alexion Europe SAS; 2016.
  • Fakhouri F, Roumenina L, Provot F, et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010;21(5):859–867.
  • McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher. 2001;16(4):202–209.
  • Owens MY, Martin JN, Wallace K, et al. Postpartum thrombotic microangiopathic syndrome. Transfus Apher Sci. 2013;48(1):51–57.
  • Iannuzzi M, Siconolfi P, D’Angelillo A, et al. A postpartum hemolytic uremic syndrome-like syndrome in a patient with pre-eclampsia: description of a clinical case. Transfus Apher Sci. 2006;34(1):11–14.
  • Obeidat B, MacDougall J, Harding K. Plasma exchange in a woman with thrombotic thrombocytopenic purpura or severe pre-eclampsia. BJOG. 2002;109(8):961–962.
  • Roberts G, Gordon MM, Porter D, et al. Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: successful outcome using plasma exchange therapy. Lupus. 2003;12(4):251–257.
  • Kozlovskaya NL, Merkusheva LI, Kirsanova TV, et al. The course and outcome of atypical haemolytic uraemic syndrome in pregnancy. Kinicheskaya Nephrologija (Clinical Nephrology). 2012;3:44–49.
  • Korotchayeva YuV, Kozlovskaya NL, Bondarenko TV, et al. The features of the course and treatment of “obstetric” haemolytic uraemic syndrome. Nephrologija (Nephrology). 2015;19(2):76–81.
  • Emirova K, Volokhina E, Tolstova E, et al. Recovery of renal function after long-term dialysis and resolution of cardiomyopathy in a patient with aHUS receiving eculizumab. BMJ Case Rep. 2016. DOI:10.1136/bcr-2015-213928

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.